Clinical Trial Update: Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life [Phase 2]

View source ↗

Summary

A Phase 2 trial of a Specific Enteral Nutrition product for malnourished patients with chronic kidney disease on hemodialysis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Specific Enteral Nutrition

Snippet

Sponsor: Lactalis | Conditions: Chronic Kidney Disease, Renal Failure Chronic Requiring Hemodialysis | Phase 2 | Status: WITHDRAWN